These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31218761)

  • 1. Clinical significance of serum IGFBP-3 in colorectal cancer.
    Hou YL; Luo P; Ji GY; Chen H
    J Clin Lab Anal; 2019 Jul; 33(6):e22912. PubMed ID: 31218761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
    Wang QJ; Zhang HC; Shen XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Expression of
    Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
    Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Karlíková M; Čurillová M; Pecen L; Karnos V; Karnos V; Topolčan O
    Anticancer Res; 2024 Jul; 44(7):3105-3113. PubMed ID: 38925804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies.
    Li Y; Jiang T; Zhang J; Zhang B; Yang W; You G; Xu K; Wu J; Luo C; Song SW
    Ann Oncol; 2012 Sep; 23(9):2415-2422. PubMed ID: 22357443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
    Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
    Mol Biotechnol; 2024 Sep; 66(9):2254-2261. PubMed ID: 37608077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
    Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
    Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
    Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
    Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
    Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
    Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
    Wang P; Li C; Ma X; Gai X
    Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
    Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
    Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
    J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.